Skip to main content
Clinical Trials/NCT03923543
NCT03923543
Completed
Not Applicable

Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease

Firat Ergin0 sites60 target enrollmentJanuary 1, 2015
ConditionsSepsis Newborn

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis Newborn
Sponsor
Firat Ergin
Enrollment
60
Primary Endpoint
Neutrophil to Lymphocyte Ratio
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The use of neutrophil lymphocyte ratio is useful for the detection of infection status in newborns after surgery

Detailed Description

The use of neutrophil lymphocyte ratio is useful for the detection of infection status in newborns after surgery and we compare this with other acute phase reactants

Registry
clinicaltrials.gov
Start Date
January 1, 2015
End Date
December 31, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

Firat Ergin

Dr. Fırat ERGİN

Tepecik Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • newborn to be operated with the diagnosis of congenital heart disease

Exclusion Criteria

  • age older than 1 month not to be operated

Outcomes

Primary Outcomes

Neutrophil to Lymphocyte Ratio

Time Frame: 2 week

We measure this with complete blood count to calculate the percentage of neutrophil count to the number of lymphocytes

Similar Trials